Clearance of fetal products and subsequent immunoreactivity of blood salvaged at Cesarean delivery

Obstetrics and Gynecology

Volumn 93, Issue 6, 1999, Pages 968-972

  Fong, Jill ^a,b   Glirewitsch, Edith D ^a   Kump, Lisa ^b   Klein, Renata ^a  

^a Obstetrics and Gynecology   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; HEMOGLOBIN;

APPARATUS; ARTICLE; BLOOD AUTOTRANSFUSION; CESAREAN SECTION; HEMATOCRIT; HUMAN; IMMUNODIFFUSION; IMMUNOREACTIVITY; MATERNAL BLOOD; PAPANICOLAOU TEST; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

BLOOD; CESAREAN SECTION; ERYTHROCYTES; FEMALE; FETUS; HUMANS; POSTOPERATIVE PERIOD;

EID: 0033032748     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006250-199906000-00015     Document Type: Article

References (24)

1. Grimes DA. A simplified device for intraoperative autotransfusion. Obstet Gynecol 1988;72:947-50.
2. Rainaldi MP, Tazzari PL, Scagliarini G, Borghi B, Conte R. Blood salvage during caesarean section. Br J Anaesth 1998;80:195-8.
3. Covone AE, Mutton D, Johnson PM, Adinolfi M. Trophoblast cells in peripheral blood from pregnant women. Lancet 1984;2:841-3.
4. Ouchterlony O, Nilsson LA. Immunodiffusion and immunoelectrophoresis. In: Weir DM, ed. Handbook of experimental immunology. Oxford, England: Blackwell Scientific, 1978;1:19.1-19.4.
5. Kindscher J. Hemolysis, plasma free hemoglobin, and washing efficiency during red blood cell scavenging. Anesth Analg 1995;80: SCA1-SCA141.
6. Kaunitz AM, Hughes JM, Grimes DA, Smith JC, Rochat RW, Kafrissen ME. Causes of maternal mortality in the United States. Obstet Gynecol 1985;65:605-12.
7. Klapholz HL. Blood transfusion in contemporary obstetric practice. Obstet Gynecol 1990;75:940-3.
8. Menitove JE. How safe is blood transfusion? In: Smith DM, Dodd RY, eds. Transfusion transmitted infections. Chicago: ASCP Press, 1991:7.
9. United States General Accounting Office. Blood supply: Transfusion-associated risks. Report to the ranking minority member, Committee on Commerce, House of Representatives. GAO/PEMD-97-2. Washington, DC: February 1997.
10. Bernstein HH, Rosenblatt MA, Gettes M, Lockwood C. The ability of the Haemonetics® cell saver system to remove tissue factor from blood contaminated with amniotic fluid. Anesth Analg 1997;85: 831-3.
11. Durand F, Duchesne-Gueguen M, LeBervet JY, Marcorelles P, Tardivel R, Vovan JM, et al. Rheologic and cytologic study of autologous blood collected with Cell Saver 4 during cesarean. Rev Fr Transfus Hemobiol 1989;32:179-91.
12. Walker RH. Fetal-maternal hemorrhage. Lab Med 1978;9:22-5.
13. Zipursky A, Pollock J, Neelands P, Chown B, Israels LG. The transplacental passage of fetal red blood cells and the pathogenesis of Rh immunisation during pregnancy. Lancet 1963;6:4S9-94.
14. Stolte L, Kessel H, van Seelen J, Eskes T, Wagatsuma T. Failure to produce the syndrome of amniotic fluid embolism by infusion of amniotic fluid and meconium into monkeys. Am J Obstet Gynecol 1967;98:694-7.
15. Kuhlman K, Hidvegi D, Tamura R, Depp R. Is amniotic fluid material in the central circulation of peripartum patients pathologic? Am J Perinatol 1985;2:295-9.
16. Clark SL, Pavlova Z, Greenspoon J, Horenstein J, Phelan J. Squamous cells in the maternal pulmonary circulation. Am J Obstet Gynecol 19S6;154:104-6.
17. Lee W, Ginsburg K, Cotton DB, Kaufman RH. Squamous and trophoblastic cells in the maternal pulmonary circulation identified by invasive hemodynamic monitoring during the peripartum period. Am J Obstet Gynecol 1986;155:999-1001.
18. Lockwood CJ, Bach R, Guha A, Zhou X, Miller WA, Nemerson Y. Amniotic fluid contains tissue factor, a potent initiator of coagulation. Am J Obstct Gynecol 1991;165:1335-41.
19. Clark SL. Arachidonic acid metabolites and the pathophysiology of amniotic fluid embolism. Semin Reprod Endocrinol 1985;3: 253-7.
20. Azegami M, Mori N. Amniotic fluid embolism and leukotrienes. Am J Obstet Gynecol 1986;155:1119-24.
21. Clark SL, Hankins GD, Dudley DA, Dildy GA, Porter TF. Amniotic fluid embolism: Analysis of the national registry. Am J Obstet Gynecol 1995;172:1158-69.
22. Clark SL. New concepts of amniotic fluid embolism: A review. Obstet Gynecol Surv 1990;45:360-8.
23. Miller GV, Ramsden CW, Primrose JN. Autologous transfusion: An alternative to transfusion with banked blood during surgery for cancer. Br J Surg 1991;78:713-5.
24. Torre GC, Ferrari M, Favre A, Razzetta F, Borgonovo G. A new technique for intraoperative blood recovery in the cancer patient. Eur J Surg Oncol 1994;20:565-70.